Syntheses and photodynamic activity of pegylated cationic Zn(II)-phthalocyanines in HEp2 cells

Theranostics

Volumn 2, Issue 9, 2012, Pages 850-870

  Ongarora, Benson G ^a   Hu, Xiaoke ^a   Verberne Sutton, Susan D ^a   Garno, Jayne C ^a   Vicente, M Graça H ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Cationic photosensitizer; PDT; Pegylation; Phthalocyanine

Indexed keywords

ETHYLENE; NITRILE; ORGANIC SOLVENT; PHTHALOCYANINE ZINC; PHTHALONITRILE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CONFORMATION; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG SYNTHESIS; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; QUANTUM YIELD; SOLUBILITY; THIN LAYER CHROMATOGRAPHY; TUMOR CELL;

EID: 84872372760     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4547     Document Type: Article

References (49)

1. Leznoff CC, Lever ABP. Phthalocyanines: Properties and Applications. VCH: Weinheim. 1996:1-4.
2. Ben-Hur E, Chan W-S. In The Porphyrin Handbook: Phthalocyanines in photobiology and their medical applications. Kadish KM, Smith KM, Guilard R. Eds. Academic Press: Boston. 2003; 19: 1-35.
3. Erk P, Hengelsberg H. In The Porphyrin Handbook: Phthalocyanines dyes and pigments. Kadish KM, Smith KM, Guilard R. Eds. Academic Press: Boston. 2003; 19: 106-146.
4. Jori G, Coppellotti O. Inactivation of pathogenic microorganisms by photodynamic techniques: mechanistic aspects and perspective applica-tions. Anti-Infective Agents in Medicinal Chemistry. 2007; 6(2): 119-131.
5. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst. 1998; 90: 889-905.
6. Pandey RK. Recent advances in photodynamic therapy. J. Porphyrins Phthalocyanines. 2000; 4: 368-373.
7. Brown SB, Brown EA, Walker I. The present and future role of photo-dynamic therapy in cancer treatment. Lancet Oncol. 2004; 5: 497-508.
8. Huang Z. A review of progress in clinical photodynamic therapy. Tech Cancer Res Treatment. 2005; 4: 283-293.
9. Baron ED, Malbasa CL, Santo-Domingo D, Fu P, Miller JD, Hanneman KK, Hsia AH, Oleinick NL, Colussi VC, Cooper KD. Silicon phthalocya-nine (Pc 4) photodynamic therapy is a safe modality for cutaneous neo-plasms: results of a Phase 1 clinical trial. Lasers Surg Med. 2010; 42(10): 728-735.
10. Kinsella TJ, Baron ED, Colussi VC, Cooper KD, Hoppel CL, Ingalls ST, Kenney ME, Li X, Oleinick NL, Stevens SR, Remick SC. Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer Pc 4 for primary or metastatic cutaneous cancers. Front Oncol. 2011; 1(14): 1-6.
11. Sokolov VV, Chissov VI, Yakubovskya RI, Aristarkhova EI, Filonenko EV, Belous TA, Vorozhtsov GN, Zharkova NN, Smirnov VV, Zhitkova MB. Photodynamic therapy (PDT) of malignant tumors by photosensi-tizer Photosens: Results of 45 clinical cases. Proceedings of SPIE (Pho-tochemistry: Photodynamic Therapy and Other Modalities). 1996; 2625: 281-287.
12. Gijsens A, Derycke A, Missiaen L, De Vos D, Huwyler J, Eberle A, De Witte P. Targeting of the photocytotoxic compound AlPcS4 to hela cells by transferrin conjugated peg-liposomes. Int J Cancer. 2002; 101: 78-85.
13. Arnida, Nishiyama N, Kanayama N, Jang W-D, Yamasaki Y, Kataoka K. PEGylated gene nanocarriers based on block catiomers bearing eth-ylenediamine repeating units directed to remarkable enhancement of photochemical transfection. J Controlled Release. 2006; 115 (2): 208-215.
14. Suzuki T, Oishi M, Nagasaki Y. Photochemical and photobiological studies of zinc phthalocyanine incorporated into PEGylated nanogels for photodynamic therapy. Journal of Photopolymer Science and Technol-ogy. 2009; 22(4): 547-550.
15. Durmus M, Ayhan MM, Gürek AG, Ahsen V. Peripherally alpha(α)-substituted novel phthalocyanines. Dyes and Pigments. 2008; 77: 570-577.
16. Bai M, Lo P-C, Ye J, Wu C, Fong W-P, NgDennis KP. Facile synthesis of pegylated zinc(II) phthalocyanines via transesterification and their in vitro photodynamic activities. Organic & Biomolecular Chemis-try. 2011; 9(20): 7028-7032.
17. Li H, Fronczek FR, Vicente MGH. Pegylated phthalocyanines: synthesis and spectroscopic properties. Tetrahedron Lett. 2011; 52: 6675-6678.
18. Hamblin MR, Miller JL, Rizvi I, Loew HG, Hasan T. Pegylation of charged polymer-photosensitizer conjugates: effects on photodynamic therapy. Br J Cancer. 2003; 89: 937-943.
19. Rovers JP, Saarnak AE, De Jode M, Sterenborg HJ, Terpstra OT, Grahn MF. Biodistribution and bioactivity of tetra-pegylated me-ta-tetra(hydroxyphenyl)chlorin compared to native me-ta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model. Photochem Photobiol. 2000; 71: 211-217.
20. Krueger T, Altermatt HJ, Mettler D, Scholl B, Magnusson L, Ris HB. Experimental photodynamic therapy for malignant pleural mesotheli-oma with pegylated mTHPC. Lasers Surg Med. 2003; 32: 61-68.
21. Fang J, Sawa T, Akaike T, Greish K, Maeda H. Enhancement of chemo-therapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer. 2004; 109: 1-8.
22. Savellano MD, Hasan T. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem Photobiol. 2003; 77: 431-439.
23. Ichikawa K, Hikita T, Maeda N, Takeuchi Y, Namba Y, Oku N. PEGyla-tion of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy. Biol Pharm Bull. 2004; 27: 443-444.
24. Wöhrle D, Iskander N, Graschew G, Sinn H, Friedrich EA, Maier-Borst W, Stern J, Schlag P. Synthesis of positively charged phthalocyanines and their activity in the Photodynamic Therapy of Cancer Cells. Photo-chem Photobiol. 1990; 51: 351-356.
25. Ball DJ, Mayhew S, Wood SR, Griffiths J, Vernon DI, Brown SB. A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge. Photochem Photobiol. 1999; 69: 390-396.
26. Duan W, Lo P-C, Duan L, Fong W-P, NgDennis KP. Preparation and in vitro photodynamic activity of amphiphilic zinc(II) phthalocyanines substituted with 2-(dimethylamino)ethylthio moieties and their N-alkylated derivatives. Bioorganic Medicinal Chemistry. 2010; 18: 2672-2677.
27. Dummin H, Cernay T, Zimmermann HW. Selective photosensitization of mitochondria in HeLa cells by cationic Zn(II) phthalocyanines with lipophilic side-chains. J Photochem Photobiol B: Biol. 1997; 37: 219-229.
28. Li H, Jensen TJ, Fronczek FR, Vicente MGH. Syntheses and Properties of a Series of Cationic Water-Soluble Phthalocyanines. J Med Chem. 2008; 51(3): 502-511.
29. Marino J, Garcia MCV, Dicelio LE, Roguin LP, Awruch J. Photodynamic effects of isosteric water-soluble phthalocyanines on human nasophar-ynx KB carcinoma cells. Eur J Med Chem. 2010; 45(9): 4129-4139.
30. Chen Z, Zhou S, Chen J, Deng Y, Luo Z, Chen H, Hamblin MR, Huang M. Pentalysine β-Carbonylphthalocyanine Zinc: an Effective Tu-mor-Targeting Photosensitizer for Photodynamic Therapy. Chem Med Chem. 2010; 5(6): 890-898.
31. Durmus M, Ahsen V. Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy. Journal of Inorganic Bio-chemistry. 2010; 104(3): 297-309.
32. Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SB. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both Gram-negative and Gram-positive bacteria. J Photochem Photobiol B: Biol. 1996; 32:159-164.
33. Mantareva V, Kussovski V, Angelov I, Wohrle D, Dimitrov R, Popova E, Dimitrov S. Non-aggregated Ga(III)-phthalocyanines in the photody-namic inactivation of planktonic and biofilm cultures of pathogenic mi-croorganisms. Photochem Photobiol Sci. 2011; 10: 91-102.
34. Tempesti TC, Alvarez MG, Durantini EN. Synthesis and photodynamic properties of amphiphilic A3B-phthalocyanine derivatives bearing N-heterocycles as potential cationic phototherapeutic agents. Dyes and Pigments. 2011; 91: 6-12.
35. Ongarora BG, Hu X, Li H, Fronczek FR, Vicente MGH. Syntheses and properties of trimethylaminophenoxy-substituted Zn(II)-phthalocyanines. Med Chem Commun. 2012; 3: 179-194.
36. Ongarora BG, Fontenot KR, Hu X, Sehgal I, Satyanarayana-Jois SD, Vicente MGH. Phthalocyanine-Peptide Conjugates for Epidermal Growth Factor Receptor Targeting. J Med Chem. 2012; 55: 3725-3738.
37. Nečas DKP. Gwyddion 2.25. Brno, Czech Republic: Czech Metrology Institute. 2009.
38. Sibrian-Vazquez M, Jensen TJ, Vicente MGH. Synthesis and cellular studies of PEG-functionalized meso-tetraphenylporphyrins. J Photochem Photobiol B: Biol. 2007; 86: 9-21.
39. Sehgal I, Sibrian-Vazquez M, Vicente MGH. Photoinduced Cytotoxicity and Biodistribution of Prostate Cancer Cell-Targeted Porphyrins. J Med Chem. 2008; 51: 6014-6020.
40. Warnecke A, Kratz F. Maleimide-oligo(ethylene glycol) Derivatives of Camptothecin as Albumin-Binding Prodrugs: Synthesis and Antitumor Efficacy. Bioconjugate Chemistry. 2003 14: 377-387.
41. Hofman J-W, Van Zeeland F, Turker S, Talsma H, Lambrechts SAG, Sakharov DV, Hennink WE, van Nostrum CF. Peripheral and Axial Substitution of Phthalocyanines with Solketal Groups: Synthesis and In Vitro Evaluation for Photodynamic Therapy. J Med Chem. 2007; 50: 1485-1494.
42. Zorlu Y, Dumoulin F, Durmuş M, Ahsen V. Comparative studies of photophysical and photochemical properties of solketal substituted platinum(II) and zinc(II) phthalocyanine sets. Tetrahedron. 2010; 66(17): 3248-3258.
43. Masilela N, Nyokong T. The synthesis and photophysical properties of water soluble tetrasulfonated, octacarboxylated and quaternised 2,(3)-tetra-(2 pyridiloxy) Ga phthalocyanines. Dyes and Pigments. 2010 84(3): 242-248.
44. Jensen TJ, Vicente MGH, Luguya R, Norton J, Fronczek FR, Smith KM. Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells. J Photochemistry and Photobiology B: Biology. 2010; 100(2): 100-111.
45. Kessel D, Luguya R, Vicente MGH. Localization and photodynamic efficacy of two cationic porphyrins varying in charge distribution. Pho-tochem. Photobiol. 2003; 78: 431-435
46. Sibrian-Vazquez M, Jensen TJ, Fronczek FR, Hammer RP, Vicente MGH. Synthesis and characterization of positively charged porphyrin-peptide conjugates. Bioconjugate Chem. 2005; 16(4): 852-863.
47. Sibrian-Vazquez M, Ortiz J, Nesterova IV, Fernández-Lázaro F, Sastre-Santos A, Soper SA, Vicente MGH. Synthesis and properties of cell-targeted Zn(II)-phthalocyanine-peptide conjugates. Bioconjugate Chem. 2007; 18: 410-420.
48. Rao RV, Hermel E, Castro-Obregon S, Del Rio G, Ellerby LM, Ellerby HM, Bredesen DE. Coupling Endoplasmic Reticulum Stress to the Cell Death Program. J. Biol. Chem. 2001; 276(36): 33869-33874.
49. Groenendyk J, Michalak M. Endoplasmic Reticulum Quality Control and Apotosis. Acta Biochim. Pol. 2005; 52: 381-395.